Synthesis of Tellurium Oxide (TeO2) Nanorods and Nanoflakes and Evaluation of Its Efficacy Against Leishmania major In Vitro and In Vivo
- 26 June 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Acta Parasitologica
- Vol. 67 (1), 143-152
- https://doi.org/10.1007/s11686-021-00445-w
Abstract
Today, the use of natural products and nanostructures has increased. Given the reports on beneficial effects of various organotellurane compounds on types of visceral leishmaniasis, we decided to investigate the effect of TeO2 NPs on Leishmania major (L. major). Tellurium can cause cell apoptosis in cancer cells without activating the caspase-pathway.Keywords
This publication has 40 references indexed in Scilit:
- In Vitro and In Vivo Activity of an Organic Tellurium Compound on Leishmania (Leishmania) chagasiPLOS ONE, 2012
- Leishmaniasis Worldwide and Global Estimates of Its IncidencePLOS ONE, 2012
- Structures, Targets and Recent Approaches in Anti-Leishmanial Drug Discovery and DevelopmentThe Open Medicinal Chemistry Journal, 2011
- Current Approaches to Discover Marine Antileishmanial Natural ProductsPlanta Medica, 2011
- Selenium‐ and Tellurium‐Containing Multifunctional Redox Agents as Biochemical Redox Modulators with Selective CytotoxicityChemistry – A European Journal, 2010
- Structure and characterization of TeO2 nanoparticles prepared in acid mediumMaterials Letters, 2009
- A Novel Organotellurium Compound (RT-01) as a New Antileishmanial AgentThe Korean Journal of Parasitology, 2009
- Bcl-2 expression and apoptosis induction in human HL60 leukaemic cells treated with a novel organotellurium(IV) compound RT-04Food and Chemical Toxicology, 2008
- Tellurium-based cysteine protease inhibitors: evaluation of novel organotellurium(IV) compounds as inhibitors of human cathepsin BBioorganic & Medicinal Chemistry Letters, 2005
- Thioredoxin reductase and cancer cell growth inhibition by organotellurium antioxidantsAnti-Cancer Drugs, 2003